Adicet Bio, Inc. (ACET)

Adicet Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	159.71	257.66	277.69	88.86	14.89
Short-Term Investments	0	0	0	10.28	51.79
Cash & Cash Equivalents	159.71	257.66	277.69	99.14	66.68
Cash Growth	-38.01%	-7.22%	180.10%	48.68%	-38.32%
Receivables	0	0	0.19	0	0
Other Current Assets	2.56	3.38	4.56	1.2	-2.5
Total Current Assets	162.27	261.04	282.44	100.34	64.19
Property, Plant & Equipment	44.2	48.98	35	25.86	2.12
Long-Term Investments	0	0	0	0	10.59
Goodwill and Intangibles	0	19.46	19.46	20.09	0
Other Long-Term Assets	0.82	1.21	2.04	7.55	4.69
Total Long-Term Assets	45.02	69.65	56.5	53.5	17.4
Total Assets	207.3	330.69	338.94	153.84	81.59
Accounts Payable	2.63	4.4	3.26	1.55	1.05
Deferred Revenue	0	0	4.81	13.98	21.88
Current Debt	3.22	2.49	1.57	1.22	0
Other Current Liabilities	13.44	12.81	6.68	5.73	-8.07
Total Current Liabilities	19.29	19.71	16.32	22.48	14.87
Long-Term Debt	17.7	18.53	19.38	20.42	0
Other Long-Term Liabilities	0.13	0.11	0.12	1.11	13.01
Total Long-Term Liabilities	17.83	18.65	19.49	21.53	13.01
Total Liabilities	37.12	38.35	35.81	44.01	27.87
Total Debt	20.92	21.02	20.94	21.64	0
Debt Growth	-0.47%	0.38%	-3.21%	-	-
Retained Earnings	-380.77	-238.11	-168.32	-106.33	-69.65
Comprehensive Income	0	0	0	0.02	0.02
Shareholders' Equity	170.18	292.34	303.13	109.83	-60.37
Net Cash / Debt	138.79	236.63	256.75	77.5	66.68
Net Cash / Debt Growth	-41.35%	-7.84%	231.28%	16.23%	-38.32%
Net Cash Per Share	3.22	5.76	8.30	10.59	31.17
Working Capital	142.99	241.33	266.12	77.86	49.32
Book Value Per Share	3.95	7.12	9.79	15.00	-28.22

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).